Qiming U.S. Ventures Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $380K | Hold |
82,871
| – | – | 1.61% | 6 |
|
2025
Q1 | $404K | Hold |
82,871
| – | – | 1.75% | 6 |
|
2024
Q4 | $557K | Hold |
82,871
| – | – | 1.09% | 6 |
|
2024
Q3 | $638K | Hold |
82,871
| – | – | 1.24% | 6 |
|
2024
Q2 | $497K | Hold |
82,871
| – | – | 0.94% | 6 |
|
2024
Q1 | $747K | Hold |
82,871
| – | – | 0.83% | 6 |
|
2023
Q4 | $785K | Hold |
82,871
| – | – | 0.72% | 8 |
|
2023
Q3 | $986K | Hold |
82,871
| – | – | 1.31% | 7 |
|
2023
Q2 | $2.03M | Hold |
82,871
| – | – | 2.13% | 7 |
|
2023
Q1 | $2.59M | Hold |
82,871
| – | – | 3.14% | 7 |
|
2022
Q4 | $5.83M | Hold |
82,871
| – | – | 7.72% | 4 |
|
2022
Q3 | $7.14M | Hold |
82,871
| – | – | 10.36% | 5 |
|
2022
Q2 | $6.85M | Hold |
82,871
| – | – | 9.51% | 5 |
|
2022
Q1 | $13.8M | Hold |
82,871
| – | – | 12.94% | 4 |
|
2021
Q4 | $13.9M | Buy |
+82,871
| New | +$13.9M | 6.38% | 6 |
|